Portfolio company
2NA FISH
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops spatial transcriptomics technology using nanotechnology and AI to provide precision diagnostics for healthcare providers and researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AKYA
This company provides spatial phenotyping solutions to researchers and clinicians for visualizing and quantifying protein and RNA expression in tissue sections.
Cubase Bio
This company develops optics-free DNA microscopy kits for three-dimensional spatial transcriptomics to support drug discovery and disease research for pharmaceutical and academic organisations.
KANVAS
This company develops spatial biology imaging technology and microbiome-based therapeutics for healthcare providers treating cancer and infectious diseases.
Nanocept
This company combines nanotechnology and diagnostics to enable early disease detection and support clinical decision-making for healthcare providers.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
Place Genomics
This company develops DNA nanotechnology and genomic analysis tools for researchers and healthcare providers to advance precision medicine and genetic research.
intoDNA
This company develops an AI-powered platform for detecting and quantifying DNA damage in cells to support pharmaceutical companies with drug development and diagnostics.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
